Clinical Trial

Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea

Study acronym: OSA-ACS-Met
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Obstructive sleep apnea (OSA) significantly increases the risk of cardiovascular events in patients with acute coronary syndrome (ACS), yet the underlying metabolic mechanisms remain unclear. This study aims to analyze the metabolic characteristics of ACS patients with OSA using metabolomics based on a prospective cohort. The study intends to construct an artificial intelligence-based risk stratification model to improve prognosis prediction and facilitate precision medicine for this population.
Trial Details
NCT Number NCT07398430
Lead Sponsor Beijing Hospital
Conditions Sleep Disordered Breathing (SDB)
Enrollment 1,200 participants
Start Date 2026-02-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-09